{"id":"https://openalex.org/W939249341","doi":null,"title":"Role of prefrontal cortex in pharmacological models of schizophrenia and antipsychotic action","display_name":"Role of prefrontal cortex in pharmacological models of schizophrenia and antipsychotic action","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W939249341","mag":"939249341"},"language":"en","primary_location":{"id":"pmh:oai:digital.csic.es:10261/33410","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10261/33410","pdf_url":null,"source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"http://purl.org/coar/resource_type/c_6501"},"parent_works":[],"lineage":["https://openalex.org/W939249341"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022624402","display_name":"Pau Celada","orcid":"https://orcid.org/0000-0002-3893-9000","observed_orcids":["https://orcid.org/0000-0002-3893-9000"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pau Celada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045533329","display_name":"Albert Adell","orcid":"https://orcid.org/0000-0003-0570-4931","observed_orcids":["https://orcid.org/0000-0003-0570-4931"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Albert Adell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071099631","display_name":"Xavier L\u00f3pez-Gil","orcid":"https://orcid.org/0000-0002-7468-6717","observed_orcids":["https://orcid.org/0000-0002-7468-6717"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xavier L\u00f3pez-Gil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089777808","display_name":"Lucila Kargieman","orcid":"https://orcid.org/0000-0002-4110-5875","observed_orcids":["https://orcid.org/0000-0002-4110-5875"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lucila Kargieman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064184266","display_name":"Noem\u00ed Santana","orcid":"https://orcid.org/0000-0003-1485-5416","observed_orcids":["https://orcid.org/0000-0003-1485-5416"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Noem\u00ed Santana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067561723","display_name":"Anal\u00eda A Bortolozzi","orcid":"https://orcid.org/0000-0002-2069-9192","observed_orcids":["https://orcid.org/0000-0002-2069-9192"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anal\u0131\u0301a Bortolozzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023104507","display_name":"Anna Casta\u00f1\u00e9","orcid":"https://orcid.org/0000-0002-2578-445X","observed_orcids":["https://orcid.org/0000-0002-2578-445X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna Casta\u00f1\u00e9","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5033849687","display_name":"Francesc Artigas","orcid":"https://orcid.org/0000-0002-5880-5720","observed_orcids":["https://orcid.org/0000-0002-5880-5720"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francesc Artigas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prefrontal-cortex","display_name":"prefrontal cortex","score":0.9599999785423279},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6549999713897705},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8519999980926514},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.8389999866485596},{"id":"https://openalex.org/keywords/mk-801","display_name":"MK-801","score":0.9829999804496765},{"id":"https://openalex.org/keywords/5-ht2a-receptor-agonists","display_name":"5-HT2A receptor agonists","score":0.9480000138282776},{"id":"https://openalex.org/keywords/digital-object-identifiers","display_name":"digital object identifiers","score":0.8230000138282776},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8709999918937683},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9240000247955322},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8949999809265137},{"id":"https://openalex.org/keywords/hyperactivity","display_name":"hyperactivity","score":0.7250000238418579},{"id":"https://openalex.org/keywords/animal-models-of-schizophrenia","display_name":"animal models of schizophrenia","score":0.6430000066757202},{"id":"https://openalex.org/keywords/positive-and-negative-symptoms","display_name":"positive and negative symptoms","score":0.6790000200271606},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.8249533176422119},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7240716814994812},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7080836296081543},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6876981854438782},{"id":"https://openalex.org/C2781195155","wikidata":"https://www.wikidata.org/wiki/Q18680","display_name":"Prefrontal cortex","level":3,"score":0.6339196562767029},{"id":"https://openalex.org/C2777836312","wikidata":"https://www.wikidata.org/wiki/Q4386371","display_name":"Dizocilpine","level":4,"score":0.6157017946243286},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.5605540871620178},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.5542873740196228},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.527789294719696},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5092290639877319},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.49982404708862305},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.49773862957954407},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.48976707458496094},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37812063097953796},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36517786979675293},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2881215810775757},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2663719952106476},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.19100016355514526},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11701521277427673}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:digital.csic.es:10261/33410","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10261/33410","pdf_url":null,"source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"mag:939249341","doi":null,"is_oa":false,"landing_page_url":"http://digital.csic.es/handle/10261/33410","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W4849013","https://openalex.org/W1720397775","https://openalex.org/W1970448316","https://openalex.org/W2005756201","https://openalex.org/W2009272831","https://openalex.org/W2017011655","https://openalex.org/W2017151426","https://openalex.org/W2020140782","https://openalex.org/W2033034887","https://openalex.org/W2037409999","https://openalex.org/W2038933762","https://openalex.org/W2042422960","https://openalex.org/W2046690663","https://openalex.org/W2084299214","https://openalex.org/W2089912569","https://openalex.org/W2111990860","https://openalex.org/W2138504515","https://openalex.org/W2162690960","https://openalex.org/W2284323937"],"related_works":["https://openalex.org/W2017011655","https://openalex.org/W2106916988","https://openalex.org/W2017151426","https://openalex.org/W1535558863","https://openalex.org/W7099641669","https://openalex.org/W2084967021","https://openalex.org/W1580988899","https://openalex.org/W1524563580","https://openalex.org/W2924261055","https://openalex.org/W2125232095"],"abstract_inverted_index":{"NMDA":[0],"receptor":[1,33],"(NMDA-R)":[2],"antagonists":[3,106,147],"are":[4,44,66],"extensively":[5],"used":[6],"as":[7,20,22],"schizophrenia":[8,48,196],"\\nmodels":[9,194],"due":[10],"to":[11,14,26,170,183],"their":[12,129],"ability":[13],"evoke":[15],"positive":[16],"and":[17,83,124,156,197],"negative":[18],"symptoms":[19],"well":[21],"cognitive":[23],"\\ndeficits":[24],"similar":[25,122],"those":[27],"of":[28,52,118,145,151,160,189,192,195,200,202],"the":[29,50,57,79,100,116,143,186,190,198],"illness.":[30],"Likewise,":[31],"5-HT2A":[32,112],"agonists":[34,113],"display":[35],"\\nhallucinogen":[36],"actions":[37,65,144],"resembling":[38],"psychotic":[39],"symptoms.":[40],"Overall,":[41],"these":[42,64,92,152],"drugs":[43],"useful":[45],"models":[46],"\\nof":[47],"for":[49],"screening":[51],"new":[53],"antipsychotic":[54,126,161,203],"drugs.":[55,204],"However,":[56],"cellular":[58],"\\nand":[59,111],"network":[60],"elements":[61],"involved":[62],"in":[63,74,91,120,134,140,154,163,178],"poorly":[67],"known.":[68],"Data":[69],"obtained":[70,98],"by":[71,99,136,174],"several":[72],"\\ngroups":[73],"recent":[75],"years":[76],"indicate":[77],"that":[78,103,159],"prefrontal":[80],"cortex":[81],"(PFC)":[82],"anatomically":[84],"related":[85],"\\nareas":[86],"play":[87],"a":[88,121,175],"major":[89],"role":[90],"actions.":[93],"This":[94],"paper":[95],"summarizes":[96],"data":[97],"authors":[101],"\\nsupporting":[102],"a)":[104],"NMDA-R":[105,146],"(phencyclidine":[107],"\u2013PCP\u2013,":[108],"dizocilpine":[109],"\u2013MK\u2013801\u2013)":[110],"(DOI)":[114],"alter":[115],"function":[117],"PFC":[119,155],"fashion,":[123],"b)":[125],"\\ndrugs":[127,166],"exert":[128],"therapeutic":[130],"action,":[131],"at":[132],"least":[133],"part,":[135],"normalizing":[137],"hyperactivity":[138],"\\nstates":[139],"PFC.":[141,179],"While":[142],"may":[148],"involve":[149],"blockade":[150],"\\nreceptors":[153],"subcortical":[157],"areas,":[158],"drugs,":[162],"particular":[164],"atypical":[165],"like":[167],"clozapine,":[168],"appear":[169],"be":[171],"mediated":[172],"essentially":[173],"local":[176],"action":[177,191,201],"These":[180],"results":[181],"\\nhelp":[182],"better":[184],"understand":[185],"neurobiological":[187],"basis":[188],"pharmacological":[193],"mode":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W939249341","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
